(Health-NewsWire.Net, April 11, 2017 ) According to the report Global Influenza Market, published by Market Data Forecast, the global market projected to reach USD 9.33 billion by 2021, at a CAGR of 8.54% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/
Influenza or flu is a transmittable respiratory disease which affects throat, lungs and nose. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be seasonal, zoonotic and pandemic. Influenza can be fatal if goes unnoticed and is regarded as a major reason of morbidity and mortality, globally. Some of the symptoms of influenza are fever, runny or stuffy nose, fatigue, cough, sore throat, headache, and body ache. According to World Health Organization, the flu occur annually infecting 5% to 10% adults and 20% to 30% children, worldwide. Approximately, 3 to 5 million people get severely infected resulting in 250,000 500,000 deaths. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample
The growth of Influenza market is majorly driven by factors such as rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, boost in Research & Development investment, and increasing government initiatives for vaccination against Influenza viruses. Additionally, a large section of population, especially in Asian and African countries is not immunized against influenza virus, thereby fueling the demand for the product in under developed and developing economies. The key constraints of the market are antigenic shift of influenza virus, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), complex regulatory framework, lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-influenza-market-1704/inquire
The products are segmented based on Product Type and Consumer and studied for a deep-level understanding of the Influenza Market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Based on Product Type:
Introduction
Vaccines
Drugs
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
Based on Type:
Introduction
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Y-o-Y Growth Analysis, By Type
Market Attractiveness Analysis, By Type
Market Share Analysis, By Type
Based on Application:
Introduction
Diagnostics Development
Drug Discovery and Development
Personalised Medicine
Disease Risk Assessment
Other Applications
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
Based on Disease Indications:
Introduction
Cancer
CardiovascularDisorders
Neurological Disorders
Immunological Disorders
Other Diseases
Y-o-Y Growth Analysis, By Disease Indications
Market Attractiveness Analysis, By Disease Indications
Market Share Analysis, By Disease Indications
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 50% in 2016.
Geographical Segmentation:
North America Influenza Market
Europe Influenza Market
Asia-pacific Influenza Market
Latin America Influenza Market
Middle East and Africa Influenza Market
The key players in Global Influenza Market are Sanofi-Pasteur (U.S.), Merck & Co. (U.S.), AstraZeneca (United Kingdom), Novartis (Switzerland), GlaxoSmithKline (U.K.), F. Hoffmann-La Roche (Switzerland), Pfizer Inc. (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), Abbott Laboratories (U.S.), CSL Limited (Australia).
Buy now http://www.marketdataforecast.com/cart/buy-now/global-influenza-market-1704
H1N1 Infection also called as swine flu is a new kind of flu in humans. Its caused by a contagious virus. H1N1 flu infects the breathing tubes in nose, lungs, and throat. The disease is contagious. When people who have it sneeze 0r cough or, they spray tiny drops of the virus into the air. Signs and symptoms include cough, stuffy, fever, sore throat, or runny nose, headache, body aches, and fatigue. Treatment includes medication (antiviral drugs).
The Influenza Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of Product Type and Consumer along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Immunotherapy Drugs market: http://www.marketdataforecast.com/market-reports/global-immunotherapy-drugs-market-1156/
Antiviral Drugs Market: http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/
Psoriasis Drugs Market: http://www.marketdataforecast.com/market-reports/global-psoriasis-drugs-market-1718/
Orphan Drugs Market: http://www.marketdataforecast.com/market-reports/global-orphan-drugs-market-1676/
Anticoccidial Drugs Market: http://www.marketdataforecast.com/market-reports/global-anticoccidial-drugs-market-13/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more info kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|